Caris Life Sciences signals beyond the news: 56+ signals from 5 sources
The latest Caris Life Sciences signal on this page is from Sep 29, 2026 (Patents): "Caris MPI, Inc.'s patent output is steady: 2 grants in the past year, 1 in the past 30 days." The busiest sources: Glassdoor (15+), LinkedIn (15+) and Website changes (15+).
Public (CAI)Biotechnology Research1,001 to 5,000 employeescarislifesciences.comLinkedIn
- Signals
- 56+
- Sources
- 5
- Last 90 days
- 44
- Latest
- Sep 29, 2026
Other signals · latest 10
Latest Caris Life Sciences signals by source
56+ signals for Caris Life Sciences across 5 sources.
Patents · Patent pace
Caris MPI, Inc.'s patent output is steady: 2 grants in the past year, 1 in the past 30 days.
Over the past year Caris MPI, Inc. received 2 US patent grants, concentrated in health tech / medical informatics and artificial intelligence / machine learning; the recent pace (2 in 90 days) is steady versus its trailing baseline.
- Grants, 12 months
- 2
- Grants, 90 days
- 2
- Grants, 30 days
- 1
- USPTO assignee
- Caris MPI, Inc.
Patents · Patent grant
Caris MPI was granted a patent for predicting platinum chemotherapy response.
In September 2026 Caris MPI patented a cancer-treatment response tool for oncology care, using molecular patient data to support chemotherapy decisions.
- Patent title
- Pan-cancer platinum response predictor
- Grant date
- Sep 8, 2026
- Inventors
- Jim Abraham, Wolfgang Michael Korn, David Spetzler
- Tech area
- health tech / medical informatics
Glassdoor · Consistent leadership complaints
Employees report toxic management and inexperienced leadership across multiple reviews
Multiple reviews mention toxic upper management, favoritism, and a lack of standard procedures, with one reviewer noting leadership is inexperienced due to fast growth.
- Overall rating
- 3.2 of 5
- CEO approval
- 46%
- Reviews read
- 5
- Review window
- Aug 18, 2026 to Sep 3, 2026
Glassdoor · Cross functional collaboration issues
Reviewers cite office politics and lack of standard procedures
Two separate reviews mention significant office politics and a general lack of standard procedures within the company, contributing to a challenging work environment.
- Overall rating
- 3.2 of 5
- CEO approval
- 46%
- Reviews read
- 5
- Review window
- Aug 18, 2026 to Sep 3, 2026
Website changes · Technical update
Caris Life Sciences reported second-quarter 2026 financial results and increased 2026 revenue guidance, driven by strong performance in molecular profiling services.
Added news item: “Caris Life Sciences Reports Second Quarter 2026 Financial Results and Increases 2026 Revenue Guidance,” stating that revenue growth was 45% driven by molecular profiling services, including approximately 59,200 clinical cases and over 114,000 whole exome/whole transcriptome tests.
- Page
- /news-and-events
Website changes · Expansion general
Caris reported growth in its precision-oncology ecosystem, with membership increasing from 95+ to 100+ worldwide and POA publications increasing from 1,050+ to 1,100+.
Added: “100+ Members Worldwide” and “1,100+ POA Publications (abstracts, posters & manuscripts).”
- Page
- /
LinkedIn
Caris MI Clarity offers a prognostic test for early-stage breast cancer distant recurrence risk.
Treatment decisions in early-stage breast cancer are often made without full visibility into late distant recurrence risk. Caris MI Clarity™ is a multimodal, computational pathology–based prognostic test that provides independent early (0–5 years) and late (5–15 years) distant recurrence risk from a single test at...
- Likes
- 26
- Comments
- 0
- Tags
- Medical Research, Healthcare Technology, Product Launch
- Initiatives
- providing independent early and late distant recurrence risk assessment
LinkedIn
Caris platform offers comprehensive tumor profiling using tissue and liquid biopsy for treatment decisions.
Why choose between tissue and liquid biopsy when both could provide critical insights? The MI Cancer Seek® platform delivers comprehensive tumor profiling, including key mutations, fusions, protein expression, TMB, GPSai® and companion diagnostic indications. Caris Assure® adds a rapid, real-time view of...
- Likes
- 74
- Comments
- 0
- Tags
- Medical Research, Healthcare Technology, Product Development, Data Science
- Initiatives
- comprehensive tumor profiling for treatment guidance
YouTube
From the Human Genome Project to 48 Hours: The Rapid Evolution of Tumor Biology
Video discusses rapid evolution of tumor biology diagnostics and the challenge of interpreting genetic data.
- Channel
- Association for Value-Based Cancer Care
- Views
- 82
- Comments
- 0
- Tags
- Precision Oncology, Tumor Biology, Genomics, Data Interpretation
YouTube
EP25 | 癌症刺客 Caris life sciences IPO
Discussion on Caris Life Sciences, a Techbio company focused on precision oncology and cancer diagnostics.
- Views
- 3
- Comments
- 0
- Tags
- Precision Oncology, Diagnostics
Showing 10 of 56+ signals. The Signal API returns all of them.
Get them with one API callSignal API · MCP
Track Caris Life Sciences with the Signal API
One POST /v1/companies/enrich call with carislifesciences.com returns Caris Life Sciences signals from 14 more signal types (reddit-company, podcast-company, glassdoor-company and more), each with its source. Or ask Claude through MCP.
2 credits per signal returned; zero-result calls are free. Endpoint reference
curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{
"domain": "carislifesciences.com",
"signal_types": ["reddit-company","podcast-company","glassdoor-company",
"product-reviews","linkedin-post-company","twitter-company-posts",
"youtube-company","website-intelligence","patents-company",
"federal-contract-award","conference-speaker","hackernews",
"producthunt-launch","seo-traffic"],
"limit": 20
}'Same industry
Other signals at related companies
Questions about Caris Life Sciences other signals
What signals does Autobound track for Caris Life Sciences besides news and filings?
What are people saying about Caris Life Sciences online?
What do employees say about working at Caris Life Sciences?
Has Caris Life Sciences been granted patents recently?
Source. Reddit, podcasts, Glassdoor, product reviews, LinkedIn, X, YouTube, company websites, patents, federal contracts, conference talks, Hacker News, Product Hunt, web traffic and employee growth, from the Signal API.
Method. The latest 15 signals per source from the last 12 months. Posts that do not name the company, replies, repeats and unreadable rows are removed. Traffic and headcount keep their newest measure.
Data as of .